Exploring the Health-Related Quality of Life of Patients Treated With Immune Checkpoint Inhibitors: Social Media Study

François-Emery Cotté   ¹ , PharmD, PhD, MPH ;   Paméla Voillot   ² , MSc ;   Bryan Bennett   ³ , PhD ;   Bruno Falissard   ^{4, 5, 6, 7} , MD, PhD ;   Christophe Tzourio   ^{8, 9} , MD, PhD ;   Pierre Foulquié   ² , MSc ;   Anne-Françoise Gaudin   ¹ , PharmD ;   Hervé Lemasson   ¹ , MSc ;   Valentine Grumberg   ¹⁰ , MSc ;   Laura McDonald   ¹¹ , PhD ;   Carole Faviez   ² , MSc ;   Stéphane Schück   ² , MD

¹ Bristol-Myers Squibb, Rueil-Malmaison, FR

² Kap Code, Paris, FR

³ Bristol-Myers Squibb, Stockport, GB

⁴ Paris-Sud University, Paris, FR

⁵ Paris-Descartes Universitiy, Paris, FR

⁶ AP-HP, Paris, FR

⁷ INSERM U1178, Paris, FR

⁸ Bordeaux University, Bordeaux, FR

⁹ Inserm U1219, Bordeaux, FR

¹⁰ UFR Pharmacy, Grenoble Alpes University, Grenoble, FR

¹¹ Bristol-Myers Squibb, London, GB